Study of radioactive ABSK011 in healthy men
This study looks at how a radioactive form of a drug called ABSK011 moves through the body in healthy male volunteers. It helps doctors understand how the drug is processed and eliminated, which is important for future cancer treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy male between 18 and 45 years old.
- Weigh at least 50 kg (110 lbs) and have a body mass index (BMI) between 19 and 26.
- Have had regular bowel movements (at least once every 1-2 days) for the past 3 months.
- Agree to use effective birth control and not donate sperm during the study and for 6 months after.
- Not have taken part in any other drug trial in the last 3 months.
- No known allergies to any drug or food, and no history of drug abuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a drug called HS-10504 is processed and eliminated from the body. Healthy male volunteers take one dose so researchers can track where the drug goes. It helps determine the right dosing and safety for future patients.
This study looks at how a new drug is processed by the body in healthy adults. It will help understand how the drug is absorbed, distributed, and eliminated.
This early-phase study tests how safe ABSK-011 is, what side effects it causes, and how the body processes the drug. It may help certain patients with advanced solid cancers (including some liver cancer cases) whose tumors have specific test results.
This study is for healthy men to see how the body processes an investigational drug called ASP3082. It is a first-in-human study, meaning it's one of the first times the drug is given to people, and the results will guide future research.
This study looks at how a new drug (RAY1225) leaves the body after a single injection. It involves healthy volunteers to track the drug over time and understand its safety.
This trial tests a new drug called ABSK211 in people with advanced solid tumors that have a change in the KRAS gene. The goal is to see if the drug is safe and works against the cancer.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.